Gut microbiota in colorectal cancer development and therapy

CC Wong, J Yu - Nature Reviews Clinical Oncology, 2023 - nature.com
Colorectal cancer (CRC) is one of the commonest cancers globally. A unique aspect of CRC
is its intimate association with the gut microbiota, which forms an essential part of the tumour …

The microbiome and gynaecological cancer development, prevention and therapy

P Łaniewski, ZE Ilhan, MM Herbst-Kralovetz - Nature Reviews Urology, 2020 - nature.com
The female reproductive tract (FRT), similar to other mucosal sites, harbours a site-specific
microbiome, which has an essential role in maintaining health and homeostasis. In the …

The role of the microbiome in cancer development and therapy

AP Bhatt, MR Redinbo… - CA: a cancer journal for …, 2017 - Wiley Online Library
Answer questions and earn CME/CNE The human body harbors enormous numbers of
microbiota that influence cancer susceptibility, in part through their prodigious metabolic …

Individualization of irinotecan treatment: a review of pharmacokinetics, pharmacodynamics, and pharmacogenetics

FM de Man, AKL Goey, RHN van Schaik… - Clinical …, 2018 - Springer
Since its clinical introduction in 1998, the topoisomerase I inhibitor irinotecan has been
widely used in the treatment of solid tumors, including colorectal, pancreatic, and lung …

Integrating rare genetic variants into pharmacogenetic drug response predictions

M Ingelman-Sundberg, S Mkrtchian, Y Zhou… - Human genomics, 2018 - Springer
Background Variability in genes implicated in drug pharmacokinetics or drug response can
modulate treatment efficacy or predispose to adverse drug reactions. Besides common …

Gut microbiota shapes the efficiency of cancer therapy

W Ma, Q Mao, W Xia, G Dong, C Yu… - Frontiers in microbiology, 2019 - frontiersin.org
Systems biology provides an opportunity to discover the role that gut microbiota play in
almost all aspects of human health. Existing evidence supports the hypothesis that gut …

The potential of the gut microbiome to reshape the cancer therapy paradigm: A review

L Liu, K Shah - JAMA oncology, 2022 - jamanetwork.com
Importance The gut microbiome, home to the vast kingdom of diverse commensal bacteria
and other microorganisms residing within the gut, was once thought to only have roles …

Irinotecan-and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives

RA Ribeiro, CWS Wanderley, DVT Wong… - Cancer chemotherapy …, 2016 - Springer
Purpose Intestinal mucositis and diarrhea are common manifestations of anticancer
regimens that include irinotecan, 5-fluorouracil (5-FU), and other cytotoxic drugs. These side …

Intestinal microbiota: a novel target to improve anti-tumor treatment?

R Villéger, A Lopès, G Carrier, J Veziant… - International journal of …, 2019 - mdpi.com
Recently, preclinical and clinical studies targeting several types of cancer strongly supported
the key role of the gut microbiota in the modulation of host response to anti-tumoral …

All You Need to Know About UGT1A1 Genetic Testing for Patients Treated With Irinotecan: A Practitioner-Friendly Guide

S Karas, F Innocenti - JCO oncology practice, 2022 - ascopubs.org
Irinotecan is an anticancer agent widely used for the treatment of solid tumors, including
colorectal and pancreatic cancers. Severe neutropenia and diarrhea are common dose …